AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2024
Sep 18, 2024
31201_dirs_2024-09-17_f2d699a0-1a5b-423e-8d9a-a40bb058f710.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2024-09-13
Reporting Person: TOBIN JAMES R (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-13 | Common Stock | G | 18000 | — | Disposed | 155146 | Indirect |
| 2024-09-13 | Common Stock | G | 18000 | — | Acquired | 18000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1925 | Direct |
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20